Federated Hermes’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.91K Buy
50
+31
+163% +$981 ﹤0.01% 1969
2025
Q4
$415 Sell
19
-31
-62% -$644 ﹤0.01% 2048
2025
Q3
$1.07K Sell
50
-227
-82% -$5.09K ﹤0.01% 2068
2025
Q2
$7.11K Sell
277
-58
-17% -$1.7K ﹤0.01% 1859
2025
Q1
$12.3K Sell
335
-1,097
-77% -$37.7K ﹤0.01% 1780
2024
Q4
$43.9K Buy
1,432
+609
+74% +$20.2K ﹤0.01% 1704
2024
Q3
$31K Buy
+823
New +$31.7K ﹤0.01% 1715
2020
Q1
Sell
-422
Closed -$18K 2245
2019
Q4
$18K Sell
422
-29
-6% -$1.18K ﹤0.01% 1845
2019
Q3
$16K Buy
+451
New +$19K ﹤0.01% 1840

Other funds holding ATEX

Federated Hermes's ATEX Position: Q1 2026 in Review

Federated Hermes increased its Anterix (ATEX) stake by 163% in Q1 2026, buying an estimated $981 and bringing the position to 50 shares worth $1.91K. The position accounts for ﹤0.01% of the portfolio, ranked #1969.

Federated Hermes first reported a position in ATEX in Q3 2019 and has held it in 9 quarters since. The position peaked at $43.9K in Q4 2024. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Federated Hermes held 50 shares of Anterix worth $1.91K as of Q1 2026.
  • Federated Hermes bought 31 Anterix shares in Q1 2026, an estimated $981.
  • Anterix made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1969 holding.
  • Federated Hermes first reported a position in Anterix in Q3 2019 and has held it in 9 quarters since.
  • Federated Hermes's Anterix position peaked at $43.9K in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.